Defining a role and functional consequences of the disordered N-terminal domain from the borna disease virus phosphoprotein
Active Project Grant Awarded Last action
- Award ID
- F31AI186526
- Recipient
-
The Washington University UEI L6NFUM28LQM5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $144,196
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 40% complete
- Place of performance
- St. Louis, MO 63110, USA
Award details come from USAspending.gov.
About this award
The National Institute of Allergy and Infectious Diseases awarded The Washington University $144,196 on November 1, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research into the functional role and biophysical characterization of the disordered N-terminal domain from the Borna disease virus phosphoprotein.
The project, led by Principal Investigator Madison A. Stringer, combines biochemical and biophysical techniques to characterize the N-terminal intrinsically disordered region (NTD) of the viral phosphoprotein and its interactions. Borna disease virus causes fatal neurological diseases in mammals; the phosphoprotein is essential for genome replication by bridging the genome to the viral polymerase. The research addresses a knowledge gap in understanding how the N-terminal IDR modulates phosphoprotein self-association, RNA binding, and polymerase activity and localization. The central hypothesis is that prolines and charged residues in the phosphoprotein sequence enhance self-association and RNA affinity, thereby altering polymerase localization and activity in cells.
Research is performed at The Washington University, St. Louis, Missouri. The period of performance runs from November 1, 2025, through April 30, 2028. The award is classified as a Project Grant under the assistance type structure of the NIH Allergy and Infectious Diseases Research program.
Description
- Abstract
- Defining a role and functional consequences of the disordered N-terminal domain from the borna disease virus phosphoprotein PI: madison a. Stringer borna disease virus causes fatal neurological diseases in mammals. Among a handful of proteins in the viral genome, phosphoprotein (P) is an essential component for genome replication. IT required for bridging the genome to the polymerase, and this bridging requires an oligomeric form of P. P itself has three domains: the central helical domain is flanked by two intrinsically disordered regions (IDRS). The helical domain binds the polymerase, the C-terminal IDR is required to bind the nucleocapsid protein, and the N-terminal IDR is required for binding RNA and driving the formation of compartmentalized viral factories in the cell. Despite its essential role in genome replication, we know very little about P, and all biochemical studies to date have focused on the folded domain. I hypothesize that the physical properties encoded in the sequence of the IDRS are important to P's functions. A major knowledge GAP is understanding how the N-terminal IDR (NTD) specifically can modulate the functions of P: its self-association, RNA binding, and how oligomerization and RNA binding properties of P can influence the activity and localization of the viral polymerase. My central hypothesis is that the prolines and charged residues in P's sequence modulate the activities of P by enhancing its self-association and affinity to RNA, ultimately altering L localization and activity in cells. To test this hypothesis, I will use a combination of biochemical and biophysical techniques to characterize the NTD and its interactions. Overall, this proposal aims to biophysically characterize P and use insights from these experiments to allow for mechanistic understanding of its function in cells. At the same time, IT will offer a fundamental opportunity to develop skills in single-molecule spectroscopy, cell biology, and virology, fostering the multidisciplinary training needed for my future as an academic biomedical investigator.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $36,622 | |
| Amendment | $564 | |
| Amendment | $0 | |
| Amendment | $564 | |
| Amendment | $0 | |
| Amendment | $35,482 | |
| Amendment | $35,482 | |
| Original award | $35,482 |
Quick answers
Who received award F31AI186526?
F31AI186526 was awarded to The Washington University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 1, 2025.
How much is award F31AI186526 worth?
$144,196 has been obligated on F31AI186526.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award